Tower Research Capital LLC (TRC) - CHINA BIOLOGIC PRODS HLDGS I ownership

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$21,000
-85.0%
177
-85.1%
0.00%
-100.0%
Q4 2020$140,000
+976.9%
1,189
+933.9%
0.00%
Q3 2020$13,000
-86.0%
115
-87.3%
0.00%
-100.0%
Q2 2020$93,000
+9200.0%
907
+11237.5%
0.00%
Q1 2020$1,000
-96.0%
8
-96.3%
0.00%
-100.0%
Q3 2019$25,000
-85.1%
215
-87.8%
0.00%
-81.8%
Q2 2019$168,000
+460.0%
1,761
+446.9%
0.01%
+450.0%
Q1 2019$30,000
-73.2%
322
-78.3%
0.00%
-75.0%
Q4 2018$112,000
+522.2%
1,484
+562.5%
0.01%
+700.0%
Q3 2018$18,000
+12.5%
224
+34.1%
0.00%0.0%
Q2 2018$16,000
-72.9%
167
-77.4%
0.00%
-80.0%
Q1 2018$59,000
+126.9%
738
+123.0%
0.01%
+66.7%
Q4 2017$26,0003310.00%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q2 2021
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 137,557$11,142,0006.62%
COMGEST GLOBAL INVESTORS S.A.S. 637,752$51,658,0001.13%
Black Creek Investment Management Inc. 411,525$33,334,0001.09%
Hillhouse Capital Management 618,391$50,090,0000.88%
RUDMAN ERROL M 21,301$1,725,0000.83%
JUPITER ASSET MANAGEMENT LTD 263,705$21,360,0000.65%
York Capital Management Global Advisors, LLC 341,616$27,671,0000.62%
VONTOBEL ASSET MANAGEMENT INC 873,968$71,525,0000.51%
Temasek Holdings (Private) Ltd 990,000$80,190,0000.44%
WASATCH ADVISORS LP 292,216$23,669,0000.31%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders